Tetraphase Pharmaceuticals Announces $8 Million Registered Direct Offering Priced At-the-Market – Business WireBy / October 30, 2019 Tetraphase Pharmaceuticals Announces $8 Million Registered Direct Offering Priced At-the-Market Business Wire Share this:TweetReddit
